Background: Type-2 diabetes mellitus (T2DM) accelerates cognitive aging and increases risk of Alzheimer’s disease. Rodent models of T2DM show altered synaptic plasticity associated with reduced learning and memory. Humans with T2DM also show cognitive deficits, including reduced learning and memory, but the relationship of these impairments to the efficacy of neuroplastic mechanisms has never been assessed.
Objective: Our primary objective was to compare mechanisms of cortical plasticity in humans with and without T2DM. Our secondary objective was to relate plasticity measures to standard measures of cognition.
Methods: A prospective cross-sectional cohort study was conducted on 21 adults with T2DM and 15 demographically-similar non-diabetic controls. Long-term potentiation-like plasticity was assessed in primary motor cortex by comparing the amplitude of motor evoked potentials (MEPs) from single-pulse transcranial magnetic stimulation before and after intermittent theta-burst stimulation (iTBS). Plasticity measures were compared between groups and related to neuropsychological scores.
Results: In T2DM, iTBS-induced modulation of MEPs was significantly less than controls, even after controlling for potential confounds. Furthermore, in T2DM, modulation of MEPs 10-min post-iTBS was significantly correlated with Rey Auditory Verbal Learning Task (RAVLT) performance.
Conclusion: Humans with T2DM show abnormal cortico-motor plasticity that is correlated with reduced verbal learning. Since iTBS after-effects and the RAVLT are both NMDA receptor-dependent measures, their relationship in T2DM may reflect brain-wide alterations in the efficacy of NMDA receptors. These findings offer novel mechanistic insights into the brain consequences of T2DM and provide a reliable means to monitor brain health and evaluate the efficacy of clinical interventions.
StrachanMWJ (2011) R D Lawrence Lecture 2010. The brain as a target organ in Type 2 diabetes: Exploring the links with cognitive impairment and dementia. Diabet Med28, 141–147.
2.
LastD, AlsopDC, AbduljalilAM, MarquisRP, de BazelaireC, HuK, CavalleranoJ, NovakV (2007) Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity. Diabetes Care30, 1193–1199.
3.
TiehuisAM, van der GraafY, VisserenFL, VinckenKL, BiesselsGJ, AppelmanAPA, KappelleLJ, MaliWPTM, Study SMART Group
(2008) Diabetes increases atrophy and vascular lesions on brain MRI in patients with symptomatic arterial disease. Stroke39, 1600–1603.
4.
Ravona-SpringerR, LuoX, SchmeidlerJ, WysockiM, LesserG, RappM, DahlmanK, GrossmanH, HaroutunianV, Schnaider BeeriM (2010) Diabetes is associated with increased rate of cognitive decline in questionably demented elderly. Dement Geriatr Cogn Disord29, 68–74.
5.
RobertsRO, KnopmanDS, GedaYE, ChaRH, PankratzVS, BaertleinL, BoeveBF, TangalosEG, IvnikRJ, MielkeMM, PetersenRC (2014) Association of diabetes with amnestic and nonamnestic mild cognitive impairment. Alzheimers Dement10, 18–26.
6.
KoekkoekPS, KappelleLJ, van den BergE, RuttenGEHM, BiesselsGJ (2015) Cognitive function in patients with diabetes mellitus: Guidance for daily care. Lancet Neurol14, 329–340.
7.
ChungC-C, PimentelD, Jor’danAJ, HaoY, MilbergW, NovakV (2015) Inflammation-associated declines in cerebral vasoreactivity and cognition in type 2 diabetes. Neurology85, 450–458.
8.
StranahanAM, ArumugamTV, CutlerRG, LeeK, EganJM, MattsonMP (2008) Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat Neurosci11, 309–317.
HuangY-Z, EdwardsMJ, RounisE, BhatiaKP, RothwellJC (2005) Theta burst stimulation of the human motor cortex. Neuron45, 201–206.
11.
FreitasC, PerezJ, KnobelM, TormosJM, ObermanL, EldaiefM, BashirS, VernetM, Peña-GómezC, Pascual-LeoneA (2011) Changes in cortical plasticity across the lifespan. Front Aging Neurosci3, 5.
12.
ObermanL, EldaiefM, FecteauS, Ifert-MillerF, TormosJM, Pascual-LeoneA (2012) Abnormal modulation of corticospinal excitability in adults with Asperger’s syndrome. Eur J Neurosci36, 2782–2788.
13.
TremblayS, VernetM, BashirS, Pascual-LeoneA, ThéoretH (2015) Theta burst stimulation to characterize changes in brain plasticity following mild traumatic brain injury: A proof-of-principle study. Restor Neurol Neurosci33, 611–620.
14.
KochG, Di LorenzoF, BonníS, PonzoV, CaltagironeC, MartoranaA (2012) Impaired LTP- but not LTD-like cortical plasticity in Alzheimer’s disease patients. J Alzheimers Dis31, 593–599.
15.
HuangY-Z, ChenR-S, RothwellJC, WenH-Y (2007) The after-effect of human theta burst stimulation is NMDA receptor dependent. Clin Neurophysiol118, 1028–1032.
16.
Di LazzaroV, PilatoF, DileoneM, ProficeP, OlivieroA, MazzoneP, InsolaA, RanieriF, MeglioM, TonaliPA, RothwellJC (2008) The physiological basis of the effects of intermittent theta burst stimulation of the human motor cortex. J Physiol586, 3871–3879.
17.
RowlandLM, AsturRS, JungRE, BustilloJR, LaurielloJ, YeoRA (2005) Selective cognitive impairments associated with NMDA receptor blockade in humans. Neuropsychopharmacology30, 633–639.
18.
RossiS, HallettM, RossiniPM, Pascual-LeoneA (2009) Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol120, 2008–2039.
19.
Peña-GomezC, Solé-PadullésC, ClementeIC, JunquéC, BargallóN, BoschB, MolinuevoJL, Valls-SoléJ, Pascual-LeoneA, Bartrés-FazD (2012) APOE status modulates the changes in network connectivity induced by brain stimulation in non-demented elders. PloS One7, e51833.
20.
ChangWH, BangOY, ShinY-I, LeeA, Pascual-LeoneA, KimY-H (2014) BDNF polymorphism and differential rTMS effects on motor recovery of stroke patients. Brain Stimulat7, 553–558.
21.
PaltaP, SchneiderALC, BiesselsGJ, TouradjiP, Hill-BriggsF (2014) Magnitude of cognitive dysfunction in adults with type 2 diabetes: A meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains. J Int Neuropsychol Soc20, 278–291.
22.
RosenbergSJ, RyanJJ, PrifiteraA (1984) Rey Auditory-Verbal Learning Test performance of patients with and without memory impairment. J Clin Psychol40, 785–787.
23.
CaleroMD, NavarroE (2004) Relationship between plasticity, mild cognitive impairment and cognitive decline. Arch Clin Neuropsychol19, 653–660.
24.
SalatD, BucknerRL, SnyderAZ, GreveDN, DesikanRS, BusaE, MorrisJC, DaleA, FischlB (2004) Thinning of the cerebral cortex in aging. Cereb Cortex14, 721–730.
25.
DesikanRS, SégonneF, FischlB, QuinnBT, DickersonBC, BlackerD, BucknerRL, DaleAM, MaguireRP, HymanBT, AlbertMS, KillianyRJ (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage31, 968–980.
26.
RossiniPM, BurkeD, ChenR, CohenLG, DaskalakisZ, Di IorioR, Di LazzaroV, FerreriF, FitzgeraldPB, GeorgeMS, HallettM, LefaucheurJP, LangguthB, MatsumotoH, MiniussiC, NitscheMA, Pascual-LeoneA, PaulusW, RossiS, RothwellJC, SiebnerHR, UgawaY, WalshV, ZiemannU (2015) Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: Basic principles and procedures for routine clinical and research application. An updated report from an I.F.C.N. Committee. Clin Neurophysiol126, 1071–1107.
27.
Valls-SoléJ, Pascual-LeoneA, WassermannEM, HallettM (1992) Human motor evoked responses to paired transcranial magnetic stimuli. Electroencephalogr Clin Neurophysiol85, 355–364.
28.
KujiraiT, CaramiaMD, RothwellJC, DayBL, ThompsonPD, FerbertA, WroeS, AsselmanP, MarsdenCD (1993) Corticocortical inhibition in human motor cortex. J Physiol471, 501–519.
29.
WischnewskiM, SchutterDJLG (2015) Efficacy and time course of theta burst stimulation in healthy humans. Brain Stimulat8, 685–692.
30.
VernetM, BashirS, YooW-K, ObermanL, MizrahiI, Ifert-MillerF, BeckCJ, Pascual-LeoneA (2014) Reproducibility of the effects of theta burst stimulation on motor cortical plasticity in healthy participants. Clin Neurophysiol125, 320–326.
31.
KochG, Di LorenzoF, BonníS, GiacobbeV, BozzaliM, CaltagironeC, MartoranaA (2014) Dopaminergic modulation of cortical plasticity in Alzheimer’s disease patients. Neuropsychopharmacol39, 2654–2661.
32.
Di LorenzoF, PonzoV, BonníS, MottaC, Negrão SerraPC, BozzaliM, CaltagironeC, MartoranaA, KochG (2016) LTP-like cortical plasticity is disrupted in Alzheimer’s disease patients independently from age of onset. Ann Neurol80, 202–210.
33.
SanthakumariR, ReddyIY, ArchanaR (2014) Effect of type 2 diabetes mellitus on brain metabolites by using proton magnetic resonance spectroscopy-a systematic review. Int J Pharma Bio Sci5, 1118–1123.
34.
KuceraP, GoldenbergZ, VarsikP, BuranovaD, TraubnerP (2005) Spinal cord lesions in diabetes mellitus. Somatosensory and motor evoked potentials and spinal conduction time in diabetes mellitus. Neuro Endocrinol Lett26, 143–147.
AbbasT, FaivreE, HölscherC (2009) Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer’s disease. Behav Brain Res205, 265–271.
LarsonJ, LynchG (1988) Role of N-methyl-D-aspartate receptors in the induction of synaptic potentiation by burst stimulation patterned after the hippocampal θ-rhythm. Brain Res441, 111–118.
40.
LabediA, BenaliA, MixA, NeubacherU, FunkeK (2014) Modulation of inhibitory activity markers by intermittent theta-burst stimulation in rat cortex is NMDA-receptor dependent. Brain Stimulat7, 394–400.
41.
MacQueenDA, DalrympleSR, DrobesDJ, DiamondDM (2016) Influence of pharmacological manipulations of NMDA and cholinergic receptors on working versus reference memory in a dual component odor span task. Learn Mem23, 270–277.
42.
Richter-LevinG, CanevariL, BlissTV (1995) Long-term potentiation and glutamate release in the dentate gyrus: Links to spatial learning. Behav Brain Res66, 37–40.
43.
ParwaniA, WeilerMA, BlaxtonTA, WarfelD, HardinM, FreyK, LahtiAC (2005) The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers. Psychopharmacology (Berl.)183, 265–274.
44.
DriesenNR, McCarthyG, BhagwagarZ, BlochMH, CalhounVD, D’SouzaDC, GueorguievaR, HeG, LeungH-C, RamaniR, AnticevicA, SuckowRF, MorganPT, KrystalJH (2013) The impact of NMDA receptor blockade on human working memory-related prefrontal function and connectivity. Neuropsychopharmacology38, 2613–2622.
45.
LevinR, Dor-AbarbanelAE, EdelmanS, DurrantAR, HashimotoK, JavittDC, Heresco-LevyU (2015) Behavioral and cognitive effects of the N-methyl-D-aspartate receptor co-agonist D-serine in healthy humans: Initial findings. J Psychiatr Res61, 188–195.
46.
KumagaiAK, VinoresSA, PardridgeWM (1996) Pathological upregulation of inner blood-retinal barrier Glut1 glucose transporter expression in diabetes mellitus. Brain Res706, 313–317.
47.
BradfordHF, ThomasAJ (1969) Metabolism of glucose and glutamate by synaptosomes from mammalian cerebral cortex. J Neurochem16, 1495–1504.
48.
HeL, XuZ, YaoK, WuG, YinY, NyachotiCM, KimSW (2015) The physiological basis and nutritional function of alpha-ketoglutarate. Curr Protein Pept Sci16, 576–581.
49.
BiesselsGJ, StaekenborgS, BrunnerE, BrayneC, ScheltensP (2006) Risk of dementia in diabetes mellitus: A systematic review. Lancet Neurol5, 64–74.
50.
ArvanitakisZ, WilsonRS, BieniasJL, EvansDA, BennettDA (2004) Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol61, 661–666.
51.
KochG, EspositoZ, KusayanagiH, MonteleoneF, CodecáC, Di LorenzoF, CaltagironeC, BernardiG, MartoranaA (2011) CSF tau levels influence cortical plasticity in Alzheimer’s disease patients. J Alzheimers Dis26, 181–186.
CraftS, BakerLD, MontineTJ, MinoshimaS, WatsonGS, ClaxtonA, ArbuckleM, CallaghanM, TsaiE, PlymateSR, GreenPS, LeverenzJ, CrossD, GertonB (2012) Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: A pilot clinical trial. Arch Neurol69, 29–38.
54.
ClaxtonA, BakerLD, WilkinsonCW, TrittschuhEH, ChapmanD, WatsonGS, CholertonB, PlymateSR, ArbuckleM, CraftS (2013) Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer’s disease. J Alzheimers Dis35, 789–797.
NovakV, MilbergW, HaoY, MunshiM, NovakP, GalicaA, ManorB, RobersonP, CraftS, AbduljalilA (2014) Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetes. Diabetes Care37, 751–759.
57.
ZhangH, HaoY, ManorB, NovakP, MilbergW, ZhangJ, FangJ, NovakV (2015) Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes. Diabetes64, 1025–1034.
58.
MaF, WuT, MiaoR, XiaoYY, ZhangW, HuangG (2014) Conversion of mild cognitive impairment to dementia among subjects with diabetes: A population-based study of incidence and risk factors with five years of follow-up. J Alzheimers Dis43, 1441–1449.
